Rhiannon N. Hardwick

1.9k total citations
33 papers, 1.4k citations indexed

About

Rhiannon N. Hardwick is a scholar working on Epidemiology, Oncology and Hepatology. According to data from OpenAlex, Rhiannon N. Hardwick has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Oncology and 9 papers in Hepatology. Recurrent topics in Rhiannon N. Hardwick's work include Liver Disease Diagnosis and Treatment (18 papers), Drug Transport and Resistance Mechanisms (15 papers) and Liver Diseases and Immunity (6 papers). Rhiannon N. Hardwick is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Drug Transport and Resistance Mechanisms (15 papers) and Liver Diseases and Immunity (6 papers). Rhiannon N. Hardwick collaborates with scholars based in United States, United Kingdom and Czechia. Rhiannon N. Hardwick's co-authors include Nathan J. Cherrington, April D. Lake, Mark J. Canet, Craig D. Fisher, John Clarke, Petr Novák, Walter T. Klimecki, George L. Scheffer, Kim L. R. Brouwer and Nathan D. Pfeifer and has published in prestigious journals such as Journal of Hepatology, Journal of Pharmacology and Experimental Therapeutics and The Annual Review of Pharmacology and Toxicology.

In The Last Decade

Rhiannon N. Hardwick

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rhiannon N. Hardwick United States	22	724	534	277	269	267	33	1.4k
April D. Lake United States	17	870 1.2×	365 0.7×	429 1.5×	160 0.6×	266 1.0×	23	1.3k
Andrew J. Lickteig United States	15	439 0.6×	391 0.7×	239 0.9×	227 0.8×	154 0.6×	25	901
María J. Perez Spain	21	388 0.5×	636 1.2×	414 1.5×	213 0.8×	216 0.8×	32	1.5k
Jonathan P. Jackson United States	15	333 0.5×	279 0.5×	233 0.8×	302 1.1×	144 0.5×	21	821
Enrique J. Sánchez Pozzi Argentina	25	288 0.4×	905 1.7×	443 1.6×	447 1.7×	224 0.8×	87	1.8k
Kazuyoshi Kon Japan	20	778 1.1×	185 0.3×	386 1.4×	526 2.0×	500 1.9×	52	1.6k
Markus G. Donner Germany	18	293 0.4×	552 1.0×	186 0.7×	112 0.4×	145 0.5×	42	1.3k
Luigi Accatino Chile	19	348 0.5×	631 1.2×	247 0.9×	131 0.5×	248 0.9×	38	1.1k
Luis A. Quiñones Chile	18	419 0.6×	172 0.3×	533 1.9×	258 1.0×	102 0.4×	86	1.4k
Lily Dara United States	16	662 0.9×	220 0.4×	589 2.1×	604 2.2×	355 1.3×	32	1.8k

Countries citing papers authored by Rhiannon N. Hardwick

Since Specialization

Citations

This map shows the geographic impact of Rhiannon N. Hardwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhiannon N. Hardwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhiannon N. Hardwick more than expected).

Fields of papers citing papers by Rhiannon N. Hardwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhiannon N. Hardwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhiannon N. Hardwick. The network helps show where Rhiannon N. Hardwick may publish in the future.

Co-authorship network of co-authors of Rhiannon N. Hardwick

This figure shows the co-authorship network connecting the top 25 collaborators of Rhiannon N. Hardwick. A scholar is included among the top collaborators of Rhiannon N. Hardwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhiannon N. Hardwick. Rhiannon N. Hardwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rusyn, Ivan, Courtney Sakolish, Yuki Kato, et al.. (2022). Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium. Toxicological Sciences. 188(2). 143–152. 27 indexed citations

Letertre, Marine P. M., Alexandros Pechlivanis, Julie A. K. McDonald, et al.. (2020). A Two-Way Interaction between Methotrexate and the Gut Microbiota of Male Sprague–Dawley Rats. Journal of Proteome Research. 19(8). 3326–3339. 47 indexed citations

Lake, April D., Rhiannon N. Hardwick, Christopher P. Leamon, Philip S. Low, & Nathan J. Cherrington. (2019). Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis. Toxicology and Applied Pharmacology. 368. 49–54. 4 indexed citations

Clarke, John, Petr Novák, April D. Lake, Rhiannon N. Hardwick, & Nathan J. Cherrington. (2017). Impaired N‐linked glycosylation of uptake and efflux transporters in human non‐alcoholic fatty liver disease. Liver International. 37(7). 1074–1081. 67 indexed citations

Canet, Mark J., Matthew D. Merrell, Rhiannon N. Hardwick, et al.. (2015). Altered Regulation of Hepatic Efflux Transporters Disrupts Acetaminophen Disposition in Pediatric Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition. 43(6). 829–835. 51 indexed citations

Canet, Mark J., Rhiannon N. Hardwick, April D. Lake, et al.. (2014). Renal Xenobiotic Transporter Expression is Altered in Multiple Experimental Models of Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition. 43(2). 266–272. 14 indexed citations

Hardwick, Rhiannon N., et al.. (2014). Fetal exposure to arsenic results in hyperglycemia, hypercholesterolemia, and nonalcoholic fatty liver disease in adult mice. 1(1). 1–1. 19 indexed citations

Hardwick, Rhiannon N., John Clarke, April D. Lake, et al.. (2014). Increased Susceptibility to Methotrexate-Induced Toxicity in Nonalcoholic Steatohepatitis. Toxicological Sciences. 142(1). 45–55. 48 indexed citations

Kyriakides, Michael, Rhiannon N. Hardwick, Zhaosheng Jin, et al.. (2014). Systems Level Metabolic Phenotype of Methotrexate Administration in the Context of Non-alcoholic Steatohepatitis in the Rat. Toxicological Sciences. 142(1). 105–116. 16 indexed citations

10.

Clarke, John, Rhiannon N. Hardwick, April D. Lake, Mark J. Canet, & Nathan J. Cherrington. (2014). Experimental Nonalcoholic Steatohepatitis Increases Exposure to Simvastatin Hydroxy Acid by Decreasing Hepatic Organic Anion Transporting Polypeptide Expression. Journal of Pharmacology and Experimental Therapeutics. 348(3). 452–458. 37 indexed citations

11.

Clarke, John, Rhiannon N. Hardwick, April D. Lake, et al.. (2014). Synergistic interaction between genetics and disease on pravastatin disposition. Journal of Hepatology. 61(1). 139–147. 45 indexed citations

12.

Canet, Mark J., Rhiannon N. Hardwick, April D. Lake, et al.. (2014). Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models. Drug Metabolism and Disposition. 42(4). 586–595. 57 indexed citations

13.

Pfeifer, Nathan D., Arlene S. Bridges, Brian C. Ferslew, Rhiannon N. Hardwick, & Kim L. R. Brouwer. (2013). Hepatic Basolateral Efflux Contributes Significantly to Rosuvastatin Disposition II: Characterization of Hepatic Elimination by Basolateral, Biliary, and Metabolic Clearance Pathways in Rat Isolated Perfused Liver. Journal of Pharmacology and Experimental Therapeutics. 347(3). 737–745. 28 indexed citations

14.

Lake, April D., Petr Novák, Rhiannon N. Hardwick, et al.. (2013). The Adaptive Endoplasmic Reticulum Stress Response to Lipotoxicity in Progressive Human Nonalcoholic Fatty Liver Disease. Toxicological Sciences. 137(1). 26–35. 106 indexed citations

15.

Canet, Mark J., Rhiannon N. Hardwick, April D. Lake, et al.. (2012). Altered Arsenic Disposition in Experimental Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 40(9). 1817–1824. 21 indexed citations

16.

Hardwick, Rhiannon N., Vijay R. More, April D. Lake, et al.. (2012). Altered UDP-Glucuronosyltransferase and Sulfotransferase Expression and Function during Progressive Stages of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 41(3). 554–561. 93 indexed citations

17.

Cherrington, Nathan J., et al.. (2012). The hepatic bile acid transporters Ntcp and Mrp2 are downregulated in experimental necrotizing enterocolitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 304(1). G48–G56. 22 indexed citations

18.

Hardwick, Rhiannon N., et al.. (2011). Molecular Mechanism of Altered Ezetimibe Disposition in Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition. 40(3). 450–460. 52 indexed citations

19.

Lake, April D., Petr Novák, Craig D. Fisher, et al.. (2011). Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 39(10). 1954–1960. 124 indexed citations

20.

Hardwick, Rhiannon N., Craig D. Fisher, Mark J. Canet, George L. Scheffer, & Nathan J. Cherrington. (2011). Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 39(12). 2395–2402. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact